Andrew Groves

Clinical trials

• A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  Site PI · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2025–2030
• A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

  Site PI · Recruiting · Phase 3

  Children's Oncology Group

  2025–2031
• Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

  Site PI · Recruiting · Phase 3

  Children's Oncology Group

  2025–2029
• Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

  Site PI · Recruiting · Phase 3

  Children's Oncology Group

  2025–2029